ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image

A Dose of a Hallucinogen from a ‘Magic Mushroom,’ and then Lasting Peace

Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.

Article
Jan Hoffman
2016
FindCenter AddIcon
FindCenter Post-Image

The Legal and Illegal Ways People Are Turning to Psychedelics as the Drug Regulator Rejects Reclassification Bid

In Melbourne's St Vincent's Hospital, down the hall from the cancer day unit, there's an unassuming room known simply as "The Retreat". This is where a select few volunteers are offered a unique opportunity: to confront their deepest fears under a heavy dose of a psychedelic.

Article
Geoff Thompson and Benjamin Sveen
2021
FindCenter AddIcon

EXPLORE TOPIC

Psilocybin